{"title":"Chiyewon","description":null,"products":[{"product_id":"ti-oss-vial","title":"Ti-Oss Bovine Cancellous Substitute Vial","description":"  \u003cdiv\u003e\n    \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Ti-Oss-vial.png?v=1781757968\" style=\"display:block;max-width:100%;justify-self:center;\" alt=\"Ti-oss Cancellous Bone Substitute — Vial and Syringe\"\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── HERO ──────────────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-hero\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-hero-tag\"\u003eChiyewon · Bone Graft\u003c\/div\u003e\n      \u003ch1 class=\"pd-hero-title\"\u003eTi-oss® Vial\u003cbr\u003eCancellous Bone Substitute\u003c\/h1\u003e\n      \u003cp class=\"pd-hero-sub\"\u003e\n        Ti-oss® is a 100% cancellous, BSE-free Australian bovine bone substitute manufactured by Chiyewon. Its\n        multiporous structure and octacalcium phosphate (OCP)-coated surface are designed to maximise blood vessel\n        ingrowth and support new bone formation, with published clinical and animal research showing performance\n        comparable to a leading deproteinized bovine bone mineral. Available in Vial and Syringe formats across\n        three particle size ranges.\n      \u003c\/p\u003e\n      \u003cdiv class=\"pd-hero-badges\"\u003e\n        \u003cspan class=\"pd-hero-badge\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003ccircle cx=\"8\" cy=\"8\" r=\"6.5\"\u003e\u003c\/circle\u003e\n            \u003cpath d=\"M5 8.5l2 2 4-4\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          100% BSE-Free Australian Bovine Bone\n        \u003c\/span\u003e\n        \u003cspan class=\"pd-hero-badge\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003cpath d=\"M3 12l4-4 3 3 4-5\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          300–400 µm Macropore Structure\n        \u003c\/span\u003e\n        \u003cspan class=\"pd-hero-badge\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003cpath d=\"M8 2v12M2 8h12\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          High Yield Volume ❨Greater cc per gram❩\n        \u003c\/span\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── CLINICAL INSIGHT ─────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eClinical Insight\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eWhat clinicians are saying\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eReal-world feedback from implantologists and oral surgeons using Ti-oss® in their\n        practices.\u003c\/p\u003e\n\n      \u003cdiv class=\"insights-grid\"\u003e\n        \u003cdiv class=\"insight-card\"\u003e\n          \u003cp class=\"insight-quote\"\u003e\n            \"For lateral window sinus grafts, what stands out with Ti-oss is how quickly the granules wet out — a\n            few drops of blood or saline and the whole graft is saturated, so packing the cavity is fast and the\n            material stays where I put it. The bone cores I've reviewed at re-entry show solid integration,\n            consistent with the published pilot data.\"\n          \u003c\/p\u003e\n          \u003cdiv class=\"insight-tag\"\u003eSinus Augmentation · Lateral Window Approach · Graft Handling\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"insight-card\"\u003e\n          \u003cp class=\"insight-quote\"\u003e\n            \"I was cautious about moving away from a product I'd used for years, but the calvarial defect data\n            showing comparable new bone formation to the industry standard DBBM at both 8 and 12 weeks gave me the\n            confidence to trial\n            Ti-oss in ridge preservation cases. Healing and graft incorporation have tracked with what I'd expect.\"\n          \u003c\/p\u003e\n          \u003cdiv class=\"insight-tag\"\u003eRidge Preservation · Comparable Performance · Clinical Confidence\u003c\/div\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── RESOURCES ─────────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section pd-section--muted\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eResources\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eClinical Documentation\u003c\/h2\u003e\n      \u003cdiv class=\"dl-grid\"\u003e\n        \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Ti-Oss_Brochure_X-DENTAL.pdf?v=1781835296\" class=\"dl-btn\" target=\"_blank\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003cpath d=\"M3 13h10M8 2v8M5 7l3 3 3-3\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          Product Brochure\n        \u003c\/a\u003e\n        \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Ti-Oss_Clinical_Study_Sinus_Augmentation.pdf?v=1781835258\" class=\"dl-btn\" target=\"_blank\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003cpath d=\"M3 13h10M8 2v8M5 7l3 3 3-3\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          Clinical Study: Sinus Augmentation\n        \u003c\/a\u003e\n        \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Ti-Oss_Evaluation_OCP_Coated_Xenograft.pdf?v=1781835267\" class=\"dl-btn\" target=\"_blank\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003cpath d=\"M3 13h10M8 2v8M5 7l3 3 3-3\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          Clinical Study: Calvarial Defect Model\n        \u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── INDICATIONS ───────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eIndications\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eWhen to use Ti-oss®\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eTi-oss® covers the core range of bone grafting indications — from socket preservation at\n        the time of extraction to maxillary sinus augmentation ahead of implant placement.\u003c\/p\u003e\n      \u003cdiv class=\"use-grid\"\u003e\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M10 4a6 6 0 100 12A6 6 0 0010 4zM10 4v2M10 14v2M4 10H2M18 10h-2\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eSinus Augmentation\u003c\/strong\u003e — Lateral window approach to graft the\n            maxillary sinus floor ahead of implant placement in the posterior maxilla.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M3 17l4-8 3 4 2-6 4 10\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eRidge Preservation\u003c\/strong\u003e — Socket grafting after extraction to maintain\n            alveolar ridge dimensions ahead of future implant placement.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M4 16l4-4 4 4 4-6\"\u003e\u003c\/path\u003e\n              \u003ccircle cx=\"16\" cy=\"5\" r=\"2\"\u003e\u003c\/circle\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eHorizontal \u0026amp; Vertical Ridge Augmentation\u003c\/strong\u003e — Reconstruction of\n            deficient ridges, typically combined with a barrier membrane.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003crect x=\"3\" y=\"5\" width=\"14\" height=\"10\" rx=\"2\"\u003e\u003c\/rect\u003e\n              \u003cpath d=\"M7 5V3m6 2V3\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003ePeri-Implant Bone Defects\u003c\/strong\u003e — Grafting around dehiscence or\n            fenestration defects identified at the time of implant placement.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M10 3c0 0-5 3-5 8a5 5 0 0010 0c0-5-5-8-5-8z\"\u003e\u003c\/path\u003e\n              \u003cpath d=\"M10 11v3M8 13h4\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eIntrabony Periodontal Defects\u003c\/strong\u003e — Filling osseous defects as part of\n            regenerative periodontal therapy.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M5 15l3-6 2 3 2-5 3 8\"\u003e\u003c\/path\u003e\n              \u003cpath d=\"M3 17h14\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eCombination GBR Procedures\u003c\/strong\u003e — Used alongside a resorbable barrier\n            membrane where guided bone regeneration is indicated.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── SCIENTIFIC EVIDENCE ──────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section pd-section--muted\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eScientific Evidence\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eTest data \u0026amp; animal studies\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eTi-oss® performance is supported by manufacturer testing across microstructural and\n        animal studies, and by independent human biopsy cases.\u003c\/p\u003e\n\n      \u003c!-- ① Multiporous Structure \u0026 Osteoconductive Surface --\u003e\n      \u003cdiv class=\"evidence-section\"\u003e\n        \u003cp class=\"evidence-title\"\u003e① Multiporous Structure \u0026amp; Osteoconductive Surface\u003c\/p\u003e\n\n        \u003cdiv class=\"evidence-row\"\u003e\n          \u003cdiv class=\"evidence-img-wrap\"\u003e\n            \u003cp class=\"evidence-sub\"\u003eMultiporosity\u003c\/p\u003e\n            \u003cdiv\u003e\n              \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/TiOss-Multiporosity.png?v=1781758468\" alt=\"Ti-oss multiporous macrostructure and pore size SEM comparison\"\u003e\n            \u003c\/div\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"evidence-img-wrap\"\u003e\n            \u003cp class=\"evidence-sub\"\u003eOsteopromoting Factor\u003c\/p\u003e\n            \u003cdiv\u003e\n              \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/TiOss-ocpsurface.png?v=1781758463\" alt=\"OCP crystals on Ti-oss surface, SEM 5000x and 50000x comparison\"\u003e\n            \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cul class=\"evidence-points\"\u003e\n          \u003cli\u003eMade from 100% cancellous bone with no cortical portion — an innovative pulverising technique creates\n            a multiporous structure designed to maximise blood vessel ingrowth\u003c\/li\u003e\n          \u003cli\u003eA pre-hydroxyapatite (Pre-HA) structure — octacalcium phosphate (OCP) crystals — is present on the\n            particle surface, a feature associated with fast bone formation in manufacturer testing\u003c\/li\u003e\n          \u003cli\u003eLow-temperature processing preserves a natural, human bone-like surface topography while avoiding the\n            vitrification associated with high-temperature manufacturing methods\u003c\/li\u003e\n        \u003c\/ul\u003e\n      \u003c\/div\u003e\n\n      \u003c!-- ② Animal Comparison: Multiporosity, Pore Size \u0026 Natural Topography --\u003e\n      \u003cdiv class=\"evidence-section\"\u003e\n        \u003cp class=\"evidence-title\"\u003e② Multiporosity, Pore Size \u0026amp; Natural Topography — Animal Comparison\u003c\/p\u003e\n\n        \u003cdiv class=\"evidence-row\"\u003e\n          \u003cdiv class=\"evidence-img-wrap\" style=\"grid-column: 1 \/ -1;\"\u003e\n            \u003cp class=\"evidence-sub\"\u003eTi-oss® vs. Competitor — Rabbit Tibia, 12 Weeks\u003c\/p\u003e\n            \u003cdiv\u003e\n              \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/TiOss-Comparison.png?v=1781758457\" alt=\"Ti-oss versus competitor rabbit tibia histology comparison at 12 weeks\"\u003e\n            \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cul class=\"evidence-points\"\u003e\n          \u003cli\u003eAngiogenesis supported by porosity design\u003c\/li\u003e\n          \u003cli\u003eOsteoblast movement supported by natural surface topography\u003c\/li\u003e\n          \u003cli\u003eFaster bone formation supported by the Pre-HA (OCP) surface structure\u003c\/li\u003e\n          \u003cli\u003eSource: Chiyewon Ti-oss® Product Brochure — rabbit tibia model, 12-week evaluation\u003c\/li\u003e\n        \u003c\/ul\u003e\n      \u003c\/div\u003e\n\n      \u003c!-- ③ Human Biopsy Results --\u003e\n      \u003cdiv class=\"evidence-section\"\u003e\n        \u003cp class=\"evidence-title\"\u003e③ Human Biopsy Results\u003c\/p\u003e\n\n        \u003cdiv class=\"evidence-row\"\u003e\n          \u003cdiv class=\"evidence-img-wrap\" style=\"grid-column: 1 \/ -1;\"\u003e\n            \u003cp class=\"evidence-sub\"\u003e3 Months \u0026amp; 4 Months Biopsy Findings\u003c\/p\u003e\n            \u003cdiv\u003e\n              \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/TiOss-HumanBiopsyResult.png?v=1781758462\" alt=\"Combined histology of new bone and Ti-oss particles across 3 to 4 month human biopsy cases\"\u003e\n            \u003c\/div\u003e\n            \u003cp class=\"evidence-caption\"\u003eClinical human biopsy case reports from multiple implant centers\u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cul class=\"evidence-points\"\u003e\n          \u003cli\u003eAcross multiple independent clinical cases, biopsy specimens taken between 3 and 4 months after\n            grafting showed new bone formation directly adjacent to Ti-oss® particles, with osteocyte lacunae\n            visible within the newly formed bone\u003c\/li\u003e\n        \u003c\/ul\u003e\n      \u003c\/div\u003e\n\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── AVAILABLE SIZES \u0026 FORMATS ────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eAvailable Formats\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eTi-oss® Vial \u0026amp; Syringe — size options\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eTi-oss® is supplied in three particle size ranges to suit different defect types, in both\n        Vial and pre-filled Syringe formats.\u003c\/p\u003e\n\n      \u003ch3 style=\"margin-top:28px;font-weight:700;\"\u003eTi-oss® Vial\u003c\/h3\u003e\n      \u003cdiv class=\"kit-table-wrap\"\u003e\n        \u003ctable class=\"kit-table\"\u003e\n          \u003cthead\u003e\n            \u003ctr\u003e\n              \u003cth\u003eSKU\u003c\/th\u003e\n              \u003cth\u003eWeight \/ Volume\u003c\/th\u003e\n              \u003cth\u003eParticle Size\u003c\/th\u003e\n            \u003c\/tr\u003e\n          \u003c\/thead\u003e\n          \u003ctbody\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25-1217\u003c\/td\u003e\n              \u003ctd\u003e0.25 g \/ 0.75 cc\u003c\/td\u003e\n              \u003ctd\u003e1.2 – 1.7 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25-0512\u003c\/td\u003e\n              \u003ctd\u003e0.25 g \/ 0.60 cc\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.2 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25-0210\u003c\/td\u003e\n              \u003ctd\u003e0.25 g \/ 0.50 cc\u003c\/td\u003e\n              \u003ctd\u003e0.2 – 1.0 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e20-1217\u003c\/td\u003e\n              \u003ctd\u003e2.00 g \/ 6.00 cc\u003c\/td\u003e\n              \u003ctd\u003e1.2 – 1.7 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e20-0512\u003c\/td\u003e\n              \u003ctd\u003e2.00 g \/ 4.50 cc\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.2 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e20-0210\u003c\/td\u003e\n              \u003ctd\u003e2.00 g \/ 4.10 cc\u003c\/td\u003e\n              \u003ctd\u003e0.2 – 1.0 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e10-1217\u003c\/td\u003e\n              \u003ctd\u003e1.00 g \/ 3.00 cc\u003c\/td\u003e\n              \u003ctd\u003e1.2 – 1.7 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e10-0512\u003c\/td\u003e\n              \u003ctd\u003e1.00 g \/ 2.30 cc\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.2 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e10-0210\u003c\/td\u003e\n              \u003ctd\u003e1.00 g \/ 2.10 cc\u003c\/td\u003e\n              \u003ctd\u003e0.2 – 1.0 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e05-1217\u003c\/td\u003e\n              \u003ctd\u003e0.50 g \/ 1.50 cc\u003c\/td\u003e\n              \u003ctd\u003e1.2 – 1.7 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e05-0512\u003c\/td\u003e\n              \u003ctd\u003e0.50 g \/ 1.20 cc\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.2 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e05-0210\u003c\/td\u003e\n              \u003ctd\u003e0.50 g \/ 1.10 cc\u003c\/td\u003e\n              \u003ctd\u003e0.2 – 1.0 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n          \u003c\/tbody\u003e\n        \u003c\/table\u003e\n      \u003c\/div\u003e\n\n      \u003ch3 style=\"margin-top:36px;font-weight:700;\"\u003eTi-oss® Syringe\u003c\/h3\u003e\n      \u003cdiv class=\"kit-table-wrap\"\u003e\n        \u003ctable class=\"kit-table\"\u003e\n          \u003cthead\u003e\n            \u003ctr\u003e\n              \u003cth\u003eSKU\u003c\/th\u003e\n              \u003cth\u003eWeight \/ Volume\u003c\/th\u003e\n              \u003cth\u003eParticle Size\u003c\/th\u003e\n            \u003c\/tr\u003e\n          \u003c\/thead\u003e\n          \u003ctbody\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS25-0210\u003c\/td\u003e\n              \u003ctd\u003e0.25 g \/ 0.55 cc\u003c\/td\u003e\n              \u003ctd\u003e0.2 – 1.0 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS05-0210\u003c\/td\u003e\n              \u003ctd\u003e0.50 g \/ 1.10 cc\u003c\/td\u003e\n              \u003ctd\u003e0.2 – 1.0 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS25-0512\u003c\/td\u003e\n              \u003ctd\u003e0.25 g \/ 0.60 cc\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.2 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS05-0512\u003c\/td\u003e\n              \u003ctd\u003e0.50 g \/ 1.20 cc\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.2 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS25-1217\u003c\/td\u003e\n              \u003ctd\u003e0.25 g \/ 0.75 cc\u003c\/td\u003e\n              \u003ctd\u003e1.2 – 1.7 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS05-1217\u003c\/td\u003e\n              \u003ctd\u003e0.50 g \/ 1.50 cc\u003c\/td\u003e\n              \u003ctd\u003e1.2 – 1.7 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n          \u003c\/tbody\u003e\n        \u003c\/table\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── SPECIFICATIONS ─────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section pd-section--muted\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eSpecifications\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eTechnical specifications\u003c\/h2\u003e\n\n      \u003ctable class=\"spec-table\"\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eDevice type\u003c\/td\u003e\n          \u003ctd\u003eXenograft bone graft material — deproteinized bovine bone mineral (DBBM), octacalcium phosphate\n            (OCP)-coated\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eMaterial origin\u003c\/td\u003e\n          \u003ctd\u003e100% cancellous bovine bone, BSE-free certified, sourced from Australia\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eSurface treatment\u003c\/td\u003e\n          \u003ctd\u003eOctacalcium phosphate (OCP) coating — Pre-HA surface structure\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eParticle size ranges\u003c\/td\u003e\n          \u003ctd\u003e0.2 – 1.0 mm · 0.5 – 1.2 mm · 1.2 – 1.7 mm\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eAvailable formats\u003c\/td\u003e\n          \u003ctd\u003eVial · Syringe\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eMacropore size\u003c\/td\u003e\n          \u003ctd\u003e300–400 µm (SEM analysis, published research)\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eManufacturer\u003c\/td\u003e\n          \u003ctd\u003eChiyewon Co., Ltd. — Gyeonggi-do, Korea\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eOrigin\u003c\/td\u003e\n          \u003ctd\u003eMade in Korea\u003c\/td\u003e\n        \u003c\/tr\u003e\n      \u003c\/table\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── CLINICAL TIPS ─────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eClinical Tips\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eGetting the most from Ti-oss®\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003ePractical guidance for predictable grafting outcomes.\u003c\/p\u003e\n\n      \u003cdiv class=\"tips-list\"\u003e\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e1\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003eMatch particle size to the defect type.\u003c\/strong\u003e The finer 0.2–1.0mm range\n            suits small extraction sockets and tight defects, while the 1.2–1.7mm range is better suited to larger\n            sinus augmentation and ridge augmentation cases that require greater space maintenance.\u003c\/div\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e2\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003eHydrate before packing.\u003c\/strong\u003e A few drops of blood, saline, or PRP at\n            the vial or syringe opening allow the multiporous particles to wet through fully before placement —\n            this is part of the intended pore design and supports close contact with the surrounding clot.\u003c\/div\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e3\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003eChoose Vial or Syringe based on surgical access.\u003c\/strong\u003e The Vial format\n            suits open-field grafting where particles are placed and packed directly, such as lateral window sinus\n            grafts, while the Syringe format suits confined or minimally invasive sites where direct, controlled\n            delivery is preferred.\u003c\/div\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e4\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003ePlan healing time around the indication.\u003c\/strong\u003e Published sinus\n            augmentation research evaluated graft maturation at 6–8 months before bone core retrieval; allow a\n            comparable healing window before proceeding to implant placement or second-stage surgery.\u003c\/div\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e5\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003eCombine with a barrier membrane where GBR is indicated.\u003c\/strong\u003e For ridge\n            augmentation or defects requiring protection against soft-tissue ingrowth, Ti-oss® is commonly used\n            alongside a resorbable collagen membrane.\u003c\/div\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv class=\"tip-warn\"\u003e\n        \u003cstrong\u003e⚠ Clinical Notice:\u003c\/strong\u003e Ti-oss® is a bone graft material derived from BSE-free certified\n        Australian bovine bone, intended for use by trained dental and oral surgical practitioners. Store per\n        manufacturer instructions and do not use if packaging is damaged or sterility is compromised. Refer to the\n        Instructions for Use for full indications, contraindications, and handling guidelines.\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e","brand":"Chiyewon","offers":[{"title":"0.25g\/0.50cc 0.2-1.0mm","offer_id":51602698338594,"sku":"25-0210","price":140.0,"currency_code":"AUD","in_stock":true},{"title":"0.50g\/1.10cc 0.2-1.0mm","offer_id":51602698371362,"sku":"05-0210","price":200.0,"currency_code":"AUD","in_stock":true},{"title":"1.00g\/2.10cc 0.2-1.0mm","offer_id":51602698404130,"sku":"10-0210","price":350.0,"currency_code":"AUD","in_stock":true},{"title":"2.00g\/4.10cc 0.2-1.0mm","offer_id":51602698436898,"sku":"20-0210","price":600.0,"currency_code":"AUD","in_stock":true},{"title":"0.25g\/0.75cc 1.2-1.7mm","offer_id":51602698469666,"sku":"25-1217","price":140.0,"currency_code":"AUD","in_stock":true},{"title":"0.50g\/1.50cc 1.2-1.7mm","offer_id":51602698502434,"sku":"05-1217","price":200.0,"currency_code":"AUD","in_stock":true},{"title":"1.00g\/3.00cc 1.2-1.7mm","offer_id":51602698535202,"sku":"10-1217","price":350.0,"currency_code":"AUD","in_stock":true},{"title":"2.00g\/6.00cc 1.2-1.7mm","offer_id":51602698567970,"sku":"20-1217","price":600.0,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Ti-Oss.png?v=1749358588"},{"product_id":"promotion-tioss-ossguide","title":"Ti-Oss® + OssGuide®","description":"\u003cul\u003e\n\u003cli style=\"font-weight: bold;\"\u003e\u003cstrong\u003eOssGuide TG1 (15mm X 20mm)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli style=\"font-weight: bold;\"\u003e\u003cstrong\u003eTi-Oss 0.25g\/0.50cc | 0.2-1.0mm\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Chiyewon","offers":[{"title":"Default Title","offer_id":50010439483682,"sku":"TG1+25-0210","price":248.0,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/promotion-tiossOssguide.png?v=1777290086"},{"product_id":"ti-oss-syringe","title":"Ti-Oss Bovine Cancellous Substitute Syringe","description":"  \u003cdiv\u003e\n    \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Ti-Oss-syringe.png?v=1781757968\" style=\"display:block;max-width:100%;justify-self:center;\" alt=\"Ti-oss Cancellous Bone Substitute — Vial and Syringe\"\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── HERO ──────────────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-hero\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-hero-tag\"\u003eChiyewon · Bone Graft\u003c\/div\u003e\n      \u003ch1 class=\"pd-hero-title\"\u003eTi-oss® Vial\u003cbr\u003eCancellous Bone Substitute\u003c\/h1\u003e\n      \u003cp class=\"pd-hero-sub\"\u003e\n        Ti-oss® is a 100% cancellous, BSE-free Australian bovine bone substitute manufactured by Chiyewon. Its\n        multiporous structure and octacalcium phosphate (OCP)-coated surface are designed to maximise blood vessel\n        ingrowth and support new bone formation, with published clinical and animal research showing performance\n        comparable to a leading deproteinized bovine bone mineral. Available in Vial and Syringe formats across\n        three particle size ranges.\n      \u003c\/p\u003e\n      \u003cdiv class=\"pd-hero-badges\"\u003e\n        \u003cspan class=\"pd-hero-badge\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003ccircle cx=\"8\" cy=\"8\" r=\"6.5\"\u003e\u003c\/circle\u003e\n            \u003cpath d=\"M5 8.5l2 2 4-4\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          100% BSE-Free Australian Bovine Bone\n        \u003c\/span\u003e\n        \u003cspan class=\"pd-hero-badge\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003cpath d=\"M3 12l4-4 3 3 4-5\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          300–400 µm Macropore Structure\n        \u003c\/span\u003e\n        \u003cspan class=\"pd-hero-badge\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003cpath d=\"M8 2v12M2 8h12\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          High Yield Volume ❨Greater cc per gram❩\n        \u003c\/span\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── CLINICAL INSIGHT ─────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eClinical Insight\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eWhat clinicians are saying\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eReal-world feedback from implantologists and oral surgeons using Ti-oss® in their\n        practices.\u003c\/p\u003e\n\n      \u003cdiv class=\"insights-grid\"\u003e\n        \u003cdiv class=\"insight-card\"\u003e\n          \u003cp class=\"insight-quote\"\u003e\n            \"For lateral window sinus grafts, what stands out with Ti-oss is how quickly the granules wet out — a\n            few drops of blood or saline and the whole graft is saturated, so packing the cavity is fast and the\n            material stays where I put it. The bone cores I've reviewed at re-entry show solid integration,\n            consistent with the published pilot data.\"\n          \u003c\/p\u003e\n          \u003cdiv class=\"insight-tag\"\u003eSinus Augmentation · Lateral Window Approach · Graft Handling\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"insight-card\"\u003e\n          \u003cp class=\"insight-quote\"\u003e\n            \"I was cautious about moving away from a product I'd used for years, but the calvarial defect data\n            showing comparable new bone formation to the industry standard DBBM at both 8 and 12 weeks gave me the\n            confidence to trial\n            Ti-oss in ridge preservation cases. Healing and graft incorporation have tracked with what I'd expect.\"\n          \u003c\/p\u003e\n          \u003cdiv class=\"insight-tag\"\u003eRidge Preservation · Comparable Performance · Clinical Confidence\u003c\/div\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── RESOURCES ─────────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section pd-section--muted\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eResources\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eClinical Documentation\u003c\/h2\u003e\n      \u003cdiv class=\"dl-grid\"\u003e\n        \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Ti-Oss_Brochure_X-DENTAL.pdf?v=1781835296\" class=\"dl-btn\" target=\"_blank\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003cpath d=\"M3 13h10M8 2v8M5 7l3 3 3-3\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          Product Brochure\n        \u003c\/a\u003e\n        \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Ti-Oss_Clinical_Study_Sinus_Augmentation.pdf?v=1781835258\" class=\"dl-btn\" target=\"_blank\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003cpath d=\"M3 13h10M8 2v8M5 7l3 3 3-3\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          Clinical Study: Sinus Augmentation\n        \u003c\/a\u003e\n        \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Ti-Oss_Evaluation_OCP_Coated_Xenograft.pdf?v=1781835267\" class=\"dl-btn\" target=\"_blank\"\u003e\n          \u003csvg viewbox=\"0 0 16 16\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.8\"\u003e\n            \u003cpath d=\"M3 13h10M8 2v8M5 7l3 3 3-3\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n          Clinical Study: Calvarial Defect Model\n        \u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── INDICATIONS ───────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eIndications\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eWhen to use Ti-oss®\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eTi-oss® covers the core range of bone grafting indications — from socket preservation at\n        the time of extraction to maxillary sinus augmentation ahead of implant placement.\u003c\/p\u003e\n      \u003cdiv class=\"use-grid\"\u003e\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M10 4a6 6 0 100 12A6 6 0 0010 4zM10 4v2M10 14v2M4 10H2M18 10h-2\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eSinus Augmentation\u003c\/strong\u003e — Lateral window approach to graft the\n            maxillary sinus floor ahead of implant placement in the posterior maxilla.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M3 17l4-8 3 4 2-6 4 10\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eRidge Preservation\u003c\/strong\u003e — Socket grafting after extraction to maintain\n            alveolar ridge dimensions ahead of future implant placement.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M4 16l4-4 4 4 4-6\"\u003e\u003c\/path\u003e\n              \u003ccircle cx=\"16\" cy=\"5\" r=\"2\"\u003e\u003c\/circle\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eHorizontal \u0026amp; Vertical Ridge Augmentation\u003c\/strong\u003e — Reconstruction of\n            deficient ridges, typically combined with a barrier membrane.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003crect x=\"3\" y=\"5\" width=\"14\" height=\"10\" rx=\"2\"\u003e\u003c\/rect\u003e\n              \u003cpath d=\"M7 5V3m6 2V3\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003ePeri-Implant Bone Defects\u003c\/strong\u003e — Grafting around dehiscence or\n            fenestration defects identified at the time of implant placement.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M10 3c0 0-5 3-5 8a5 5 0 0010 0c0-5-5-8-5-8z\"\u003e\u003c\/path\u003e\n              \u003cpath d=\"M10 11v3M8 13h4\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eIntrabony Periodontal Defects\u003c\/strong\u003e — Filling osseous defects as part of\n            regenerative periodontal therapy.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cdiv class=\"use-item\"\u003e\n          \u003cdiv class=\"use-icon\"\u003e\n            \u003csvg viewbox=\"0 0 20 20\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"1.6\"\u003e\n              \u003cpath d=\"M5 15l3-6 2 3 2-5 3 8\"\u003e\u003c\/path\u003e\n              \u003cpath d=\"M3 17h14\"\u003e\u003c\/path\u003e\n            \u003c\/svg\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"use-text\"\u003e\n\u003cstrong\u003eCombination GBR Procedures\u003c\/strong\u003e — Used alongside a resorbable barrier\n            membrane where guided bone regeneration is indicated.\u003c\/div\u003e\n        \u003c\/div\u003e\n\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── SCIENTIFIC EVIDENCE ──────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section pd-section--muted\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eScientific Evidence\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eTest data \u0026amp; animal studies\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eTi-oss® performance is supported by manufacturer testing across microstructural and\n        animal studies, and by independent human biopsy cases.\u003c\/p\u003e\n\n      \u003c!-- ① Multiporous Structure \u0026 Osteoconductive Surface --\u003e\n      \u003cdiv class=\"evidence-section\"\u003e\n        \u003cp class=\"evidence-title\"\u003e① Multiporous Structure \u0026amp; Osteoconductive Surface\u003c\/p\u003e\n\n        \u003cdiv class=\"evidence-row\"\u003e\n          \u003cdiv class=\"evidence-img-wrap\"\u003e\n            \u003cp class=\"evidence-sub\"\u003eMultiporosity\u003c\/p\u003e\n            \u003cdiv\u003e\n              \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/TiOss-Multiporosity.png?v=1781758468\" alt=\"Ti-oss multiporous macrostructure and pore size SEM comparison\"\u003e\n            \u003c\/div\u003e\n          \u003c\/div\u003e\n          \u003cdiv class=\"evidence-img-wrap\"\u003e\n            \u003cp class=\"evidence-sub\"\u003eOsteopromoting Factor\u003c\/p\u003e\n            \u003cdiv\u003e\n              \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/TiOss-ocpsurface.png?v=1781758463\" alt=\"OCP crystals on Ti-oss surface, SEM 5000x and 50000x comparison\"\u003e\n            \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cul class=\"evidence-points\"\u003e\n          \u003cli\u003eMade from 100% cancellous bone with no cortical portion — an innovative pulverising technique creates\n            a multiporous structure designed to maximise blood vessel ingrowth\u003c\/li\u003e\n          \u003cli\u003eA pre-hydroxyapatite (Pre-HA) structure — octacalcium phosphate (OCP) crystals — is present on the\n            particle surface, a feature associated with fast bone formation in manufacturer testing\u003c\/li\u003e\n          \u003cli\u003eLow-temperature processing preserves a natural, human bone-like surface topography while avoiding the\n            vitrification associated with high-temperature manufacturing methods\u003c\/li\u003e\n        \u003c\/ul\u003e\n      \u003c\/div\u003e\n\n      \u003c!-- ② Animal Comparison: Multiporosity, Pore Size \u0026 Natural Topography --\u003e\n      \u003cdiv class=\"evidence-section\"\u003e\n        \u003cp class=\"evidence-title\"\u003e② Multiporosity, Pore Size \u0026amp; Natural Topography — Animal Comparison\u003c\/p\u003e\n\n        \u003cdiv class=\"evidence-row\"\u003e\n          \u003cdiv class=\"evidence-img-wrap\" style=\"grid-column: 1 \/ -1;\"\u003e\n            \u003cp class=\"evidence-sub\"\u003eTi-oss® vs. Competitor — Rabbit Tibia, 12 Weeks\u003c\/p\u003e\n            \u003cdiv\u003e\n              \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/TiOss-Comparison.png?v=1781758457\" alt=\"Ti-oss versus competitor rabbit tibia histology comparison at 12 weeks\"\u003e\n            \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cul class=\"evidence-points\"\u003e\n          \u003cli\u003eAngiogenesis supported by porosity design\u003c\/li\u003e\n          \u003cli\u003eOsteoblast movement supported by natural surface topography\u003c\/li\u003e\n          \u003cli\u003eFaster bone formation supported by the Pre-HA (OCP) surface structure\u003c\/li\u003e\n          \u003cli\u003eSource: Chiyewon Ti-oss® Product Brochure — rabbit tibia model, 12-week evaluation\u003c\/li\u003e\n        \u003c\/ul\u003e\n      \u003c\/div\u003e\n\n      \u003c!-- ③ Human Biopsy Results --\u003e\n      \u003cdiv class=\"evidence-section\"\u003e\n        \u003cp class=\"evidence-title\"\u003e③ Human Biopsy Results\u003c\/p\u003e\n\n        \u003cdiv class=\"evidence-row\"\u003e\n          \u003cdiv class=\"evidence-img-wrap\" style=\"grid-column: 1 \/ -1;\"\u003e\n            \u003cp class=\"evidence-sub\"\u003e3 Months \u0026amp; 4 Months Biopsy Findings\u003c\/p\u003e\n            \u003cdiv\u003e\n              \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/TiOss-HumanBiopsyResult.png?v=1781758462\" alt=\"Combined histology of new bone and Ti-oss particles across 3 to 4 month human biopsy cases\"\u003e\n            \u003c\/div\u003e\n            \u003cp class=\"evidence-caption\"\u003eClinical human biopsy case reports from multiple implant centers\u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003cul class=\"evidence-points\"\u003e\n          \u003cli\u003eAcross multiple independent clinical cases, biopsy specimens taken between 3 and 4 months after\n            grafting showed new bone formation directly adjacent to Ti-oss® particles, with osteocyte lacunae\n            visible within the newly formed bone\u003c\/li\u003e\n        \u003c\/ul\u003e\n      \u003c\/div\u003e\n\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── AVAILABLE SIZES \u0026 FORMATS ────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eAvailable Formats\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eTi-oss® Vial \u0026amp; Syringe — size options\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003eTi-oss® is supplied in three particle size ranges to suit different defect types, in both\n        Vial and pre-filled Syringe formats.\u003c\/p\u003e\n\n      \u003ch3 style=\"margin-top:36px;font-weight:700;\"\u003eTi-oss® Syringe\u003c\/h3\u003e\n      \u003cdiv class=\"kit-table-wrap\"\u003e\n        \u003ctable class=\"kit-table\"\u003e\n          \u003cthead\u003e\n            \u003ctr\u003e\n              \u003cth\u003eSKU\u003c\/th\u003e\n              \u003cth\u003eWeight \/ Volume\u003c\/th\u003e\n              \u003cth\u003eParticle Size\u003c\/th\u003e\n            \u003c\/tr\u003e\n          \u003c\/thead\u003e\n          \u003ctbody\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS25-0210\u003c\/td\u003e\n              \u003ctd\u003e0.25 g \/ 0.55 cc\u003c\/td\u003e\n              \u003ctd\u003e0.2 – 1.0 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS05-0210\u003c\/td\u003e\n              \u003ctd\u003e0.50 g \/ 1.10 cc\u003c\/td\u003e\n              \u003ctd\u003e0.2 – 1.0 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS25-0512\u003c\/td\u003e\n              \u003ctd\u003e0.25 g \/ 0.60 cc\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.2 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS05-0512\u003c\/td\u003e\n              \u003ctd\u003e0.50 g \/ 1.20 cc\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.2 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS25-1217\u003c\/td\u003e\n              \u003ctd\u003e0.25 g \/ 0.75 cc\u003c\/td\u003e\n              \u003ctd\u003e1.2 – 1.7 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS05-1217\u003c\/td\u003e\n              \u003ctd\u003e0.50 g \/ 1.50 cc\u003c\/td\u003e\n              \u003ctd\u003e1.2 – 1.7 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n          \u003c\/tbody\u003e\n        \u003c\/table\u003e\n      \u003c\/div\u003e\n\n      \u003ch3 style=\"margin-top:28px;font-weight:700;\"\u003eTi-oss® Vial\u003c\/h3\u003e\n      \u003cdiv class=\"kit-table-wrap\"\u003e\n        \u003ctable class=\"kit-table\"\u003e\n          \u003cthead\u003e\n            \u003ctr\u003e\n              \u003cth\u003eSKU\u003c\/th\u003e\n              \u003cth\u003eWeight \/ Volume\u003c\/th\u003e\n              \u003cth\u003eParticle Size\u003c\/th\u003e\n            \u003c\/tr\u003e\n          \u003c\/thead\u003e\n          \u003ctbody\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25-1217\u003c\/td\u003e\n              \u003ctd\u003e0.25 g \/ 0.75 cc\u003c\/td\u003e\n              \u003ctd\u003e1.2 – 1.7 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25-0512\u003c\/td\u003e\n              \u003ctd\u003e0.25 g \/ 0.60 cc\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.2 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25-0210\u003c\/td\u003e\n              \u003ctd\u003e0.25 g \/ 0.50 cc\u003c\/td\u003e\n              \u003ctd\u003e0.2 – 1.0 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e20-1217\u003c\/td\u003e\n              \u003ctd\u003e2.00 g \/ 6.00 cc\u003c\/td\u003e\n              \u003ctd\u003e1.2 – 1.7 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e20-0512\u003c\/td\u003e\n              \u003ctd\u003e2.00 g \/ 4.50 cc\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.2 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e20-0210\u003c\/td\u003e\n              \u003ctd\u003e2.00 g \/ 4.10 cc\u003c\/td\u003e\n              \u003ctd\u003e0.2 – 1.0 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e10-1217\u003c\/td\u003e\n              \u003ctd\u003e1.00 g \/ 3.00 cc\u003c\/td\u003e\n              \u003ctd\u003e1.2 – 1.7 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e10-0512\u003c\/td\u003e\n              \u003ctd\u003e1.00 g \/ 2.30 cc\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.2 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e10-0210\u003c\/td\u003e\n              \u003ctd\u003e1.00 g \/ 2.10 cc\u003c\/td\u003e\n              \u003ctd\u003e0.2 – 1.0 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e05-1217\u003c\/td\u003e\n              \u003ctd\u003e0.50 g \/ 1.50 cc\u003c\/td\u003e\n              \u003ctd\u003e1.2 – 1.7 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e05-0512\u003c\/td\u003e\n              \u003ctd\u003e0.50 g \/ 1.20 cc\u003c\/td\u003e\n              \u003ctd\u003e0.5 – 1.2 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e05-0210\u003c\/td\u003e\n              \u003ctd\u003e0.50 g \/ 1.10 cc\u003c\/td\u003e\n              \u003ctd\u003e0.2 – 1.0 mm\u003c\/td\u003e\n            \u003c\/tr\u003e\n          \u003c\/tbody\u003e\n        \u003c\/table\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── SPECIFICATIONS ─────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section pd-section--muted\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eSpecifications\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eTechnical specifications\u003c\/h2\u003e\n\n      \u003ctable class=\"spec-table\"\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eDevice type\u003c\/td\u003e\n          \u003ctd\u003eXenograft bone graft material — deproteinized bovine bone mineral (DBBM), octacalcium phosphate\n            (OCP)-coated\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eMaterial origin\u003c\/td\u003e\n          \u003ctd\u003e100% cancellous bovine bone, BSE-free certified, sourced from Australia\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eSurface treatment\u003c\/td\u003e\n          \u003ctd\u003eOctacalcium phosphate (OCP) coating — Pre-HA surface structure\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eParticle size ranges\u003c\/td\u003e\n          \u003ctd\u003e0.2 – 1.0 mm · 0.5 – 1.2 mm · 1.2 – 1.7 mm\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eAvailable formats\u003c\/td\u003e\n          \u003ctd\u003eVial · Syringe\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eMacropore size\u003c\/td\u003e\n          \u003ctd\u003e300–400 µm (SEM analysis, published research)\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eManufacturer\u003c\/td\u003e\n          \u003ctd\u003eChiyewon Co., Ltd. — Gyeonggi-do, Korea\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n          \u003ctd\u003eOrigin\u003c\/td\u003e\n          \u003ctd\u003eMade in Korea\u003c\/td\u003e\n        \u003c\/tr\u003e\n      \u003c\/table\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- ── CLINICAL TIPS ─────────────────────────────────────────── --\u003e\n  \u003cdiv class=\"pd-section\"\u003e\n    \u003cdiv class=\"pd-inner\"\u003e\n      \u003cdiv class=\"pd-label\"\u003eClinical Tips\u003c\/div\u003e\n      \u003ch2 class=\"pd-h2\"\u003eGetting the most from Ti-oss®\u003c\/h2\u003e\n      \u003cp class=\"pd-lead\"\u003ePractical guidance for predictable grafting outcomes.\u003c\/p\u003e\n\n      \u003cdiv class=\"tips-list\"\u003e\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e1\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003eMatch particle size to the defect type.\u003c\/strong\u003e The finer 0.2–1.0mm range\n            suits small extraction sockets and tight defects, while the 1.2–1.7mm range is better suited to larger\n            sinus augmentation and ridge augmentation cases that require greater space maintenance.\u003c\/div\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e2\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003eHydrate before packing.\u003c\/strong\u003e A few drops of blood, saline, or PRP at\n            the vial or syringe opening allow the multiporous particles to wet through fully before placement —\n            this is part of the intended pore design and supports close contact with the surrounding clot.\u003c\/div\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e3\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003eChoose Vial or Syringe based on surgical access.\u003c\/strong\u003e The Vial format\n            suits open-field grafting where particles are placed and packed directly, such as lateral window sinus\n            grafts, while the Syringe format suits confined or minimally invasive sites where direct, controlled\n            delivery is preferred.\u003c\/div\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e4\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003ePlan healing time around the indication.\u003c\/strong\u003e Published sinus\n            augmentation research evaluated graft maturation at 6–8 months before bone core retrieval; allow a\n            comparable healing window before proceeding to implant placement or second-stage surgery.\u003c\/div\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"tip-item\"\u003e\n          \u003cdiv class=\"tip-num\"\u003e5\u003c\/div\u003e\n          \u003cdiv class=\"tip-body\"\u003e\n\u003cstrong\u003eCombine with a barrier membrane where GBR is indicated.\u003c\/strong\u003e For ridge\n            augmentation or defects requiring protection against soft-tissue ingrowth, Ti-oss® is commonly used\n            alongside a resorbable collagen membrane.\u003c\/div\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv class=\"tip-warn\"\u003e\n        \u003cstrong\u003e⚠ Clinical Notice:\u003c\/strong\u003e Ti-oss® is a bone graft material derived from BSE-free certified\n        Australian bovine bone, intended for use by trained dental and oral surgical practitioners. Store per\n        manufacturer instructions and do not use if packaging is damaged or sterility is compromised. Refer to the\n        Instructions for Use for full indications, contraindications, and handling guidelines.\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e","brand":"Chiyewon","offers":[{"title":"Syringe 0.25g\/0.55cc 0.2-1.0mm","offer_id":51604720943394,"sku":"S25-0210","price":150.0,"currency_code":"AUD","in_stock":true},{"title":"Syringe 0.50g\/1.10cc 0.2-1.0mm","offer_id":51604720976162,"sku":"S05-0210","price":220.0,"currency_code":"AUD","in_stock":true},{"title":"Syringe 0.25g\/0.75cc 1.2-1.7mm","offer_id":51604721041698,"sku":"S25-1217","price":150.0,"currency_code":"AUD","in_stock":true},{"title":"Syringe 0.50g\/1.50cc 1.2-1.7mm","offer_id":51604721074466,"sku":"S05-1217","price":220.0,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/files\/Ti-Oss_syringe.png?v=1751380891"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0900\/3588\/0226\/collections\/Chiyewon.png?v=1786095997","url":"https:\/\/xdentalsupplies.com.au\/collections\/chiyewon.oembed","provider":"X Dental Supplies","version":"1.0","type":"link"}